NewsWhore
03-08-2010, 01:20 PM
AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG's Avastin in tests for use as an initial treatment against colon cancer.
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/32905930/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/32905930/)